To assess the effectiveness of a treatment in phase II clinical trial for cancer study, an adaptive multi-stage design, especially a two-stage one, is commonly used. This type of design allows an on-going study to end early for the participant\u27s safety and design\u27s efficiency. Since a large value of the response rate p for the treatment is wanted, lower one-sided confidence intervals for p are of interest. Due to the limited sample size, exact intervals with a guaranteed confidence level are derived using a rank function that is based on the Clopper–Pearson lower confidence limit. When the sample size in stage 2 is a constant, two kinds of smallest intervals are constructed with or without using the sufficiency principle. The proposed...
Objectives: In phase II clinical trials in oncology, the potential efficacy of a new treatment regim...
Background: Designing trials to reduce treatment duration is important in several therapeutic areas,...
The main purpose of a single-arm phase II cancer trial of a new regimen is to determine whether it ...
To assess the effectiveness of a treatment in phase II clinical trial for cancer study, an adaptive ...
To assess the effectiveness of a treatment in phase II clinical trial for cancer study, an adaptive ...
Abstract Background Recently, several adaptive one-arm two-stage designs have been developed by full...
AbstractThe Simon two-stage optimal design is often used for phase II cancer clinical trials. A stud...
An adaptive treatment strategy (ATS) is defined as a sequence of treatments and intermediate respons...
An adaptive treatment strategy (ATS) is defined as a sequence of treatments and intermediate respons...
In phase II clinical trials on cancer, it is of great interest to establish the efficacy and safety ...
In phase II clinical trials on cancer, it is of great interest to establish the efficacy and safety ...
In phase II clinical trials on cancer, it is of great interest to establish the efficacy and safety ...
In phase II clinical trials on cancer, it is of great interest to establish the efficacy and safety ...
Simon’s two-stage designs are widely used in cancer phase II clinical trials for assessing the effic...
Simon’s two-stage designs are widely used in cancer phase II clinical trials for assessing the effic...
Objectives: In phase II clinical trials in oncology, the potential efficacy of a new treatment regim...
Background: Designing trials to reduce treatment duration is important in several therapeutic areas,...
The main purpose of a single-arm phase II cancer trial of a new regimen is to determine whether it ...
To assess the effectiveness of a treatment in phase II clinical trial for cancer study, an adaptive ...
To assess the effectiveness of a treatment in phase II clinical trial for cancer study, an adaptive ...
Abstract Background Recently, several adaptive one-arm two-stage designs have been developed by full...
AbstractThe Simon two-stage optimal design is often used for phase II cancer clinical trials. A stud...
An adaptive treatment strategy (ATS) is defined as a sequence of treatments and intermediate respons...
An adaptive treatment strategy (ATS) is defined as a sequence of treatments and intermediate respons...
In phase II clinical trials on cancer, it is of great interest to establish the efficacy and safety ...
In phase II clinical trials on cancer, it is of great interest to establish the efficacy and safety ...
In phase II clinical trials on cancer, it is of great interest to establish the efficacy and safety ...
In phase II clinical trials on cancer, it is of great interest to establish the efficacy and safety ...
Simon’s two-stage designs are widely used in cancer phase II clinical trials for assessing the effic...
Simon’s two-stage designs are widely used in cancer phase II clinical trials for assessing the effic...
Objectives: In phase II clinical trials in oncology, the potential efficacy of a new treatment regim...
Background: Designing trials to reduce treatment duration is important in several therapeutic areas,...
The main purpose of a single-arm phase II cancer trial of a new regimen is to determine whether it ...